Swan NeuroTech
PrivateLast Round
Grant
May 28, 2024
Total Funding Raised
$20,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Swan NeuroTech is a biotechnology company that develops biodegradable, biomaterial-based drug delivery implants designed to facilitate peripheral nerve repair and regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swan NeuroTech Comparables
Compare Swan NeuroTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renerva, Inc. | 90% | |
| BioCircuit Technologies | 87% | |
| Neuraptive Therapeutics | 78% |
Swan NeuroTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 148% MoM.
Swan NeuroTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Swan NeuroTech's valuation, stock price, and market status.
Is Swan NeuroTech a public or private company?
Swan NeuroTech is a private company.
What is the current stock price of Swan NeuroTech?
Swan NeuroTech is a private company with no public stock price. No recent secondary market data is available.
How much is Swan NeuroTech worth (valuation)?
Valuation information for Swan NeuroTech is not publicly available.
Can I buy Swan NeuroTech stock?
Swan NeuroTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Swan NeuroTech's last funding round?
Swan NeuroTech's most recent funding round was Grant on May 28, 2024.
Who are the main investors in Swan NeuroTech?
Investor information for Swan NeuroTech is not publicly disclosed.
Will Swan NeuroTech IPO soon?
No public IPO plans have been announced for Swan NeuroTech.
How can I track Swan NeuroTech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Swan NeuroTech's secondary market activity and sign up for updates.